Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma [Phase 4]
A Phase 4 randomized trial comparing evening dosing of Xalacom versus Cosopt in glaucoma patients completed.
-
CLINICAL_TRIALS trial_result · 2021-02-08Clinical Trial Update: Comparison of Efficacy and Ocular Surface Disease Assessment Between Monoprost and BAK-preserved Latanoprost [Phase 4]
Phase 4 trial comparing efficacy and ocular surface outcomes between Monoprost and BAK-preserved latanoprost in glaucoma and ocular hyperten…
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within Scandinavia [Phase 3]
Phase 3 trial update for open angle glaucoma or ocular hypertension conducted in Scandinavia; study completed.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within the United Kingdom [Phase 3]
Phase 3 clinical trial in the United Kingdom evaluating treatment for open angle glaucoma or ocular hypertension; study status completed.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the US [Phase 4]
A phase 4 trial comparing latanoprost with travoprost and bimatoprost in patients with elevated intraocular pressure, completed in the US.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular Hypertension [Phase 2]
A Phase 2 trial comparing latanoprost formulations to Xalatan for primary open-angle glaucoma and ocular hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-angle Glaucoma [Phase 4]
Phase 4 trial assessing 3 months of latanoprost to reduce intraocular pressure in ocular hypertension or open-angle glaucoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: Efficacy, Tolerability and Safety of RKI983 (0.05% & 0.10%) vs Xalatan in Patients With POAG or Ocular Hypertension [Phase 1, Phase 2]
A clinical trial update comparing RKI983 at 0.05% and 0.10% to Xalatan in patients with primary open-angle glaucoma or ocular hypertension; …
-
CLINICAL_TRIALS trial_result · 2020-12-04Clinical Trial Update: Tafluprost Preservative Free Switch Study [Phase 4]
Phase 4 trial update on a tafluprost preservative-free switch study for glaucoma patients.
-
CLINICAL_TRIALS trial_result · 2020-12-01Clinical Trial Update: Generic Travoprost Versus Brand Name Travoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension [Phase 4]
Phase 4 trial comparing generic travoprost to brand-name travoprost in primary open-angle glaucoma or ocular hypertension; results posted af…
-
CLINICAL_TRIALS trial_result · 2020-12-01Clinical Trial Update: Comparison of Efficacy and Ocular Surface Disease Assessment Between BRIDIN-T Eye Drops 0.15% and ALPHAGAN-P Eye Drops 0.15% in Glaucoma or Ocular Hypertensive Patients : Phase 4, Parallel Group Design, Investigator-blind, Active-control, Randomized, Multi-center Trial [Phase 4]
Phase 4 randomized trial comparing BRIDIN-T 0.15% eye drops to ALPHAGAN-P 0.15% eye drops for efficacy and ocular surface disease in glaucom…
-
CLINICAL_TRIALS trial_result · 2020-11-27Clinical Trial Update: Effect of Alternate Therapies on Intraocular Pressure in Ocular Hypertension [NA]
Completed clinical trial examining how alternate therapies affect intraocular pressure in ocular hypertension; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-11-05Clinical Trial Update: 180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma [NA]
Clinical trial comparing 180-degree versus 360-degree selective laser trabeculoplasty as initial therapy for glaucoma has completed with res…
-
CLINICAL_TRIALS trial_result · 2020-11-04Clinical Trial Update: SYL040012, Treatment for Open Angle Glaucoma [Phase 2]
Phase 2 trial update for SYL040012 in open angle glaucoma and ocular hypertension has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-23Clinical Trial Update: A Phase IIb Safety and Efficacy Study of DE-126 Ophthalmic Solution in Primary Open-Angle Glaucoma or Ocular Hypertension- Angel Study [Phase 2]
Phase IIb study of DE-126 ophthalmic solution in open-angle glaucoma or ocular hypertension completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Efficacy and Systemic Safety of Netarsudil 0.01%, 0.02%, 0.04% Relative to Placebo in Subjects With Open-angle Glaucoma or Ocular Hypertension in Japan [Phase 2]
Phase 2 trial evaluating the efficacy and systemic safety of netarsudil at 0.01%, 0.02%, and 0.04% versus placebo in open-angle glaucoma or …
-
CLINICAL_TRIALS trial_result · 2020-09-29Clinical Trial Update: Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting [Phase 4]
Phase 4 real-world study of Rhopressa for reducing elevated intraocular pressure in glaucoma or ocular hypertension completed with posted re…
-
CLINICAL_TRIALS trial_result · 2020-09-25Clinical Trial Update: IOP Patterns in Ocular Hypertensive Patients Newly Converted to Glaucoma vs Stable Ocular Hypertensive Patients [NA]
Clinical trial update on optic nerve head pressure patterns in ocular hypertensive patients who converted to glaucoma versus those remaining…
-
CLINICAL_TRIALS trial_result · 2020-08-27Clinical Trial Update: Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma [Phase 2]
Phase 2 dose-finding trial comparing latanoprost to a novel glaucoma treatment, with completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-27Clinical Trial Update: A Phase 2, Dose Finding Study of PF-03187207 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension. [Phase 2]
Phase 2 dose-finding trial of PF-03187207 in primary open-angle glaucoma or ocular hypertension completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-04Clinical Trial Update: Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Once Daily and Twice Daily in Subjects With Primary Open-Angle Glaucoma SPECTRUM 6 [Phase 2]
Phase 2 trial assessing safety and efficacy of DE-117 ophthalmic solution administered once daily and twice daily in primary open-angle glau…
-
CLINICAL_TRIALS trial_result · 2020-06-25Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of CKD-351 [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of CKD-351 for primary open angle glaucoma and ocular hypertension.
-
CLINICAL_TRIALS trial_result · 2020-06-04Clinical Trial Update: Dose-Ranging Study of the Bimatoprost Ocular Insert [Phase 2]
Phase 2 dose-ranging study of the bimatoprost ocular insert for open-angle glaucoma and ocular hypertension completed.
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial update on the efficacy and safety of bimatoprost sustained-release (SR) for open-angle glaucoma or ocular hypertension has com…
-
CLINICAL_TRIALS trial_result · 2020-04-02Clinical Trial Update: Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01 % and Lumigan® 0.03% Unit Dose [Phase 4]
Phase 4 trial comparing Monoprost with Lumigan formulations for safety and efficacy in primary open angle glaucoma and ocular hypertension; …